[(125)I]Iodo-ASEM, a specific in vivo radioligand for α7-nAChR.

about

[(125)I]Iodo-ASEM, a specific in vivo radioligand for α7-nAChR.

Item

http://www.wikidata.org/entity/Q39294038

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

2014年论文

@zh

2014年论文

@zh-cn

name

[(125)I]Iodo-ASEM, a specific in vivo radioligand for α7-nAChR.

@en

[(125)I]Iodo-ASEM, a specific in vivo radioligand for α7-nAChR.

@nl

type

Item

label

[(125)I]Iodo-ASEM, a specific in vivo radioligand for α7-nAChR.

@en

[(125)I]Iodo-ASEM, a specific in vivo radioligand for α7-nAChR.

@nl

prefLabel

[(125)I]Iodo-ASEM, a specific in vivo radioligand for α7-nAChR.

@en

[(125)I]Iodo-ASEM, a specific in vivo radioligand for α7-nAChR.

@nl

P1476

[(125)I]Iodo-ASEM, a specific in vivo radioligand for α7-nAChR.

@en

P2093

Andrew G Horti

http://www.w3.org/2001/XMLSchema#string

Kenneth J Kellar

http://www.w3.org/2001/XMLSchema#string

Martin G Pomper

http://www.w3.org/2001/XMLSchema#string

Robert F Dannals

http://www.w3.org/2001/XMLSchema#string

Ronnie C Mease

http://www.w3.org/2001/XMLSchema#string

Thao T Olson

http://www.w3.org/2001/XMLSchema#string

Yongjun Gao

http://www.w3.org/2001/XMLSchema#string

P2860

Proof-of-concept trial of an alpha7 nicotinic agonist in schizophrenia

Mammalian nicotinic acetylcholine receptors: from structure to function

Regional distribution of nicotinic receptor subunit mRNAs in human brain: comparison between Alzheimer and normal brain

The comparative pharmacology and up-regulation of rat neuronal nicotinic receptor subtype binding sites stably expressed in transfected mammalian cells

Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin

Nicotinic receptor abnormalities in Alzheimer's disease.

International Union of Pharmacology. XX. Current status of the nomenclature for nicotinic acetylcholine receptors and their subunits.

Pre-clinical properties of the alpha4beta2 nicotinic acetylcholine receptor partial agonists varenicline, cytisine and dianicline translate to clinical efficacy for nicotine dependence.

The brain alpha7 nicotinic receptor may be an important therapeutic target for the treatment of Alzheimer's disease: studies with DMXBA (GTS-21).

Alzheimer's disease and the basal forebrain cholinergic system: relations to beta-amyloid peptides, cognition, and treatment strategies.

P304

488-493

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.NUCMEDBIO.2014.12.008

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2014-12-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25687449

http://www.w3.org/2001/XMLSchema#string

P932

4387010

http://www.w3.org/2001/XMLSchema#string